Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Structural and functional diversity of paraoxonases

Several forms of a paraoxonase enzyme provide different degrees of protection against organophosphate chemicals.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hyde, E.G. & Carmichael, W.W. Anatoxin-a (S), a naturally occurring organo-phosphate, is an irreversible active site-directed inhibitor of acetyl-cholinesterase (EC 3.1.1. 7). J. Biochem. Toxicol. 6, 195–201 (1991).

    Article  CAS  Google Scholar 

  2. La Du, B.N. Human serum paraoxonase/arylesterase. in Pharmacogenetics of Drug Metabolism (ed. Karlow, W.) 51–91 (Pergamon, New York, 1992).

    Google Scholar 

  3. Davies, H.G. et al. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nature Genet. 14, 334–336 (1996).

    Article  CAS  Google Scholar 

  4. Broomfield, C.A. & Ford, K.W. Hydrolysis of nerve agents by plasma enzymes. in Cholinesterases (ed Massoulie, J.). 307 (American Chemical Society, Washington, DC, 1991).

    Google Scholar 

  5. St Clair, M.H. et al. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253, 1557–1559 (1991).

    Article  CAS  Google Scholar 

  6. Adkins, S., Can, K.N., Mody, M. & La Du, B.N. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: Glutamine or arginine at position 191, for the respective A or B allozymes. Am. J. Hum. Genet. 52, 598–608 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Humbert, R. et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nature Genet. 3, 73–76 (1993).

    Article  CAS  Google Scholar 

  8. Watson, A.D. et al. Protective effect of high density lipoprotein-associated paraoxonase: Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96, 2882–2891 (1995).

    Article  CAS  Google Scholar 

  9. Sorenson, R.C., Primo-Parmo, S.L., Camper, S.A. & La Du, B.N. The genetic mapping and gene structure of mouse paraoxonase/arylesterase. Genomics 30, 431–438 (1995).

    Article  CAS  Google Scholar 

  10. Primo-Parmo, S.L., Sorenson, R.C., Teiber, J. & The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33, 498–507 (1996).

    Article  CAS  Google Scholar 

  11. Ruiz, J.H. et al. The polymorphism (Gln-Argl92) of the high-density lipoprotein-bound enzyme paraoxonase is an independent cardiovascular risk factor in non-insulin-dependent diabetic patients. Lancet 346, 869–872 (1995).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

La Du, B. Structural and functional diversity of paraoxonases. Nat Med 2, 1186–1187 (1996). https://doi.org/10.1038/nm1196-1186

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1196-1186

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing